BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 50 filers reported holding BIOTA PHARMACEUTIALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $76,000 | -70.3% | 50,465 | -61.8% | 0.00% | – |
| Q4 2015 | $256,000 | +282.1% | 131,946 | +292.4% | 0.00% | – |
| Q3 2015 | $67,000 | -45.1% | 33,628 | -43.1% | 0.00% | – |
| Q2 2015 | $122,000 | -11.6% | 59,092 | -1.7% | 0.00% | – |
| Q1 2015 | $138,000 | -63.8% | 60,143 | -64.6% | 0.00% | – |
| Q4 2014 | $381,000 | -11.6% | 169,946 | -2.5% | 0.00% | – |
| Q3 2014 | $431,000 | -20.0% | 174,393 | -7.7% | 0.00% | – |
| Q2 2014 | $539,000 | +26.2% | 188,970 | +170.7% | 0.00% | – |
| Q1 2014 | $427,000 | +60.5% | 69,808 | +10.0% | 0.00% | – |
| Q4 2013 | $266,000 | -38.0% | 63,444 | -38.2% | 0.00% | – |
| Q3 2013 | $429,000 | +10.6% | 102,691 | -8.7% | 0.00% | – |
| Q2 2013 | $388,000 | +361.9% | 112,516 | +434.8% | 0.00% | – |
| Q4 2012 | $84,000 | – | 21,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,407,700 | $3,153,000 | 0.92% |
| Broadfin Capital, LLC | 5,223,422 | $11,700,000 | 0.51% |
| Avoro Capital Advisors LLC | 258,586 | $579,000 | 0.39% |
| RA Capital Management | 1,378,770 | $3,088,000 | 0.33% |
| BVF INC/IL | 435,900 | $976,000 | 0.19% |
| Dominick & Dominick LLC | 150,166 | $336,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $358,000 | 0.16% |
| KNOTT DAVID M | 268,327 | $601,052,000 | 0.14% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $656,000 | 0.09% |
| Baker Brothers Advisors | 1,106,910 | $2,479,000 | 0.02% |